Endometriosis

Three-dimensional ultrasound (3D US) is a new imaging modality, which is being introduced into clinical practice. Although this technique will not probably replace two-dimensional ultrasound, it is being increasingly used.

Endometrial stromal sarcoma (ESS) is a rare malignant tumor of the endometrium, occurring in the age group of 40-50 years.

Endometrial cancer remains the most commonly diagnosed gynecologic cancer in the United States. In fact, the number of women affected by the disease continues to rise despite a slight decline in annual incidence rates in the past 30 years.

The use of opioid risk-reduction strategies by primary care physicians is limited, even among patients at particular risk of misuse, according to a study published online Feb. 24 in the Journal of General Internal Medicine.

Uterine risk factors (RF) strongly influence survival of women with endometrial cancer, independent of nodal metastasis, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.

A 30 y/o woman, P1001, sought a second opinion from me regarding the following situation: She just had her first baby, and has a history of symptomatic endometriosis including some difficulty in achieving pregnancy (but did so without medical intervention). She was advised by another physician that she should use either depo or the progestin only pill for the next 6-12 months (while she is breastfeeding) to prevent the progression of endometriosis.

When laproscopic treatment of endometriosis didn't work what should you do?

NICHD, Endometriosis, and Female Infertility Research

Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology

Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology

Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology

Coverage of the 37th Annual Global Congress on Minimally Invasive Gynecology

Coverage of 36th AAGL Congress November 2007, Washington, DC

SGO Annual Meeting on Women’s Cancer in San Diego from March 3-7, 2007

SGO Annual Meeting on Women’s Cancer in San Diego from March 3-7, 2007